These chemoresistant NEPCa cells may arise following androgen deprivation therapy with anti-androgens and, as previously mentioned in the HSP90 section, can even confer drug resistance to their neighboring PCa cells. The gene discussed is HSP90AB1; the disease is posterior cortical atrophy.